It is generally accepted that homeostasis normally ensures tight regulation of ROS levels since the highly reactive molecules can easily inflict damage on cellular constituents. By contrast, deficient production of ROS may also have deleterious consequences as illustrated by the serious clinical picture of chronic granulomatous disease, in which phagocytic superoxide production is practically absent [5] , or by congenital hypothyroidism caused by Duox2 deficiency [6] . Considering the widespread expression of non-phagocytic Nox/Duox enzymes, and their presence in vital organs, it is reasonable to believe that altered activity of other Nox/Duox enzymes can also contribute to disease pathogenesis (Table 1) . In cases where the pathogenic role of certain Nox/Duox isoforms is caused by increased activity, pharmacological inhibition may have therapeutic potential [7] . However, to obtain a fair assessment of the feasibility of therapeutic Nox inhibition, the physiological functions of different isoforms should be identified.
To this end, the phenotypic analysis of knockout animals may provide information about the physiological functions of specific NADPH oxidase isoforms. Studying disease development and progression in knockout animals also offers the possibility of uncovering the role of Nox enzymes
Trends
Members of the Nox/Duox NADPH oxidase family produce ROS in a regulated manner in several different cells and tissues.
Pharmacological inhibition of non-phagocytic Nox/Duox enzymes might have therapeutic potential.
Several studies have described the disease-modifying phenotypes of Nox1 and Nox4 knockouts.
The lack of Nox4-derived ROS can lead to aggravated disease development, which is in contrast to the prevailing dogma that considers ROS to be generally harmful.
in disease pathogenesis. This latter experimental approach is particularly important in the process of drug target identification. Genetic models of Nox/Duox deficiency are also crucial tools when expression of these enzymes is examined at the protein level, as using knockout samples in western blot or immunostaining experiments is the ultimate control to prove the specificity of an antibody. In this review, we discuss the results of studies involving mouse models with Nox/Duox deficiency. The complex host defense problem that develops in the absence of a functional phagocytic oxidase and the role of Nox2 in other disease models have been covered in several papers [1, 5, 8] , therefore they are not discussed in this work. Since non-phagocytic Nox/Duox isoforms are expressed in various cells and tissues, this review necessarily includes the discussion of findings from seemingly unrelated experimental models. Even so, the results discussed here are connected in a way that they all reflect the consequences of the absence of Nox/Duox-derived ROS.
Nox1
Nox1 was the first homolog of Nox2 (formerly known as gp91 phox [ 1 _ T D $ D I F F ] ) to be identified [9] . Nox1 is highly expressed in the colon (Figure 1 ), where it localizes to epithelial cells. Similar to its phagocytic counterpart, Nox1 functions in a complex with p22 phox [10] . To form a superoxide-producing enzyme complex, Nox1 requires two additional proteins, NOXO1 and NOXA1, which are also present in the colon epithelium [11] . Nox1-deficient mice were first created by Matsuno et al., who described no obvious abnormality of the animals [12] .
In spite of the fact that the colon has the highest level of Nox1 expression, surprisingly little is known about the function of Nox1 in this organ. The colon is normally inhabited by a huge number of bacteria; thus, the presence of Nox1 and its regulators in the colon, along with the homology between the phagocytic and colon oxidases suggest a role in host defense. However, disturbed antimicrobial function in Nox1 knockout animals has not yet been reported. Coant et al. showed that progenitor cells in the colon of Nox1 knockout mice are converted into goblet cells in higher numbers than that in wild-type animals [13] . The increase in goblet cell number was paralleled by the reduced number of colonocytes. Cell fate in the colon is controlled by Wnt and Notch1 signaling, and ROS produced by the colon oxidase may influence these pathways through the redox regulation of PTEN and NF-kB [13] . Recent data suggest that bacteria may have a significant role in controlling cell proliferation in the colon through Nox1. Jones et al. have shown that Lactobacilli stimulate ROS production and proliferation of intestinal epithelial cells in a Nox1-dependent manner [14] . ROS production by the colon oxidase might also contribute to mucosal repair after injury. In an intestinal epithelial-specific Nox1 knockout model, mucosal healing was impaired in Nox1 knockouts [15] . This deficiency is likely explained by a previously unknown signaling pathway, in which the activity of Nox1 is regulated by an endogenous N-formyl peptide receptor ligand, annexin 1. Nox1-derived ROS then stimulate epithelial cell Box 
NADPH Oxidases
The story of NADPH oxidases stems from phagocyte research. When exposed to foreign pathogens, phagocytic cellssuch as neutrophil granulocytes -produce large amounts of superoxide. Superoxide and its derivatives (ROS) have a crucial role in the killing of the invading pathogens. ROS act like a 'double-edged sword', meaning that they are essential for killing pathogens; however, they can also be harmful to host tissues. In phagocytic cells, superoxide (O 2 -Á) is produced by the NADPH oxidase enzyme, which transfers electrons from NADPH to molecular oxygen. The 'core' of this enzyme is a heme-binding, flavoprotein Nox2 (formerly known as gp91 phox ), which catalyzes the final steps of electron transfer. It was known for some time that besides phagocytes, other types of mammalian cells synthesize and release ROS, which can serve various biological functions. However, the enzymatic background of non-phagocytic ROS production was unknown. Beginning from 1999, several enzymes were identified at the molecular level, which are now proven to be responsible for regulated ROS production observed in diverse tissues. These proteins are highly homologous to the phagocytic NADPH oxidase and are now designated the Nox/Duox family of NADPH oxidases. The Nox family of NADPH oxidases consists of the following members: Nox1, Nox2, Nox3, Nox4, Nox5, Duox1, and Duox2. The discovery of this enzyme family has stimulated ROS research since we can now assign a specific source of ROS in several tissues, including the gastrointestinal tract, kidney, heart, lung, thyroid, inner ear, and blood vessels.
migration and wound repair through the oxidative inactivation of protein phosphatases PTEN and PTP-PEST [15] . Several lines of evidence suggest that ROS contribute to the development of inflammatory bowel disease [16, 17] . In this regard, a potential role of Nox1 is particularly interesting since the enzyme is located in the colon epithelial cells themselves while previously only inflammatory cells were considered as a ROS source. Glutathione peroxidase-1 and -2 double knockout mice develop spontaneous ileocolitis, the severity of which is dependent on the genetic background. When these mice were crossed with Nox1 knockout animals, the severity of the colitis was reduced, thus proving a role for Nox1-derived ROS in the inflammatory process [18] . In contrast to this finding, the absence of Nox1 in IL-10-deficient animals induced intestinal inflammation, which is probably caused by endoplasmic reticulum stress, developing in double knockout goblet cells [19] .
The expression of Nox1 is not restricted to the colon epithelium, as the enzyme has been described in several other cell types, including vascular smooth muscle cells [9] . Angiotensin II
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Nox1 Nox5 infusion induces increased blood pressure in mice, and this response is attenuated in the genetic absence of Nox1 [12, 20] . One study reported decreased basal blood pressure in Nox1 knockout animals [20] , while another group did not find such a difference [12] . The absence of Nox1 might be protective against angiotensin II-induced hypertension because the lack of superoxide increases the bioavailability of nitric oxide. Matsuno et al. found that vascular hypertrophy stimulated by angiotensin II was unchanged in the absence of Nox1 [12] , while Gavazzi et al. reported reduced aorta hypertrophy, characterized by decreased accumulation of extracellular matrix [20] . In Nox1 knockout animals, angiotensin II-elicited aortic dissection is less severe, and this protective effect is unlikely due to lower blood pressure since norepinephrine treatment induces hypertension but fails to induce dissections in wild-type or Nox1 knockout mice [21] . In angiotensin II-infused Nox1 knockout animals, the expression level of tissue inhibitor of metalloproteinase 1 (TIMP-1) is increased when compared with wild-type mice. The elevation of TIMP-1 level in the vascular wall can reduce the activity of matrix metalloproteinases (MMPs), which may be behind the lower occurrence of aortic dissections in Nox1 knockouts [21] . In a transgenic model of hypertension, where active human renin is produced under the control of the transthyretin promoter, deletion of Nox1 did not reduce blood pressure, while oxidative stress was less prominent in the knockouts [22] . There is also evidence that oxidative stress elicited by hyperglycemia in endothelial cells is mediated by Nox1 [23] . Furthermore, in an experimental model of diabetes mellitus, ApoE-deficient mice develop less severe atherosclerosis when the nox1 gene is also disrupted [23] .
Nox1 mRNA is also present in neurons, although the expression has never been demonstrated at the protein level. We also know little about the expression of NOXO1 and NOXA1 in neurons. This is an important problem since the mere demonstration of Nox1 mRNA expression does not necessarily prove that a Nox1-based oxidase complex is active in the cell.
Nox1 mRNA expression was detected in dorsal root ganglion (DRG) neurons and Nox1-deficient animals show attenuated response to inflammatory pain [24] . Chemical mediators of inflammatory pain augment the capsaicin-induced calcium signal through the activation of TRPV1 channel, and this regulatory effect was found to be altered in Nox1 knockouts. The same group reported that in the absence of Nox1 the analgesic effect of morphine was potentiated, and analgesic tolerance was suppressed [25] . Further experiments that include an attempt to identify each component of the Nox1-based oxidase complex in DRG neurons are clearly needed before we can appreciate the physiological significance of the above-discussed observations.
Working with the same Nox1-deficient mouse line, conflicting results have been published about the role of Nox1 in the development of ischemic injury of the brain. Kahles et al. observed a significant reduction of infarct size at 24 h following a 1 h ischemic period implemented by the occlusion of the middle cerebral artery (MCAO) [26] . The beneficial effect of Nox1 deletion no longer existed if the occlusion lasted 2 h or longer. In a similar study, Jackman et al. applied MCAO for only 0.5 h and analyzed the injury also after 24 h [27] . They found no difference in total infarct volume; however, a 4-fold greater cortical infarct volume was observed in Nox1 knockouts, suggesting that the activity of Nox1 could be protective in the cortex. In contrast to these studies, Kleinschnitz et al. reported no difference in lesion size and functional outcome between wild-type and Nox1 knockout animals [28] .
Nox1 is also expressed in microglia, where Nox2 appears to be the other dominant Nox isoform [29] . When lipopolysaccharide (LPS) was injected into the striatum of Nox1 knockouts and wildtype animals, nitrotyrosine formation was reduced in the knockouts, implicating Nox1 in the formation of peroxynitrite. This activity may inflict damage on neurons since in the LPS-injected region of Nox1 knockouts, a reduced loss of synapsin (a marker of presynaptic terminals) was detected [29] .
Nox3
Among NADPH oxidases, Nox3 seems to have the most restricted expression pattern in the mammalian organism. Nox3 is specifically localized to the inner ear (Figure 1 ), where it is required for the proper development of otoconia crystals of the vestibular system. This unique function of Nox3 was first revealed by successful positional cloning of several mutant mouse alleles at the head tilt (het) locus on chromosome 17 [30] . Mutations at this locus lead to severe balance and spatial orientation defects of adult mice. All these mutants caused loss of function of the nox3 gene [30] .
The specific role of Nox3 in vestibular development was further corroborated by a study identifying an NADPH oxidase organizer 1 (Noxo1) mutation responsible for the head slant (hslt) mouse phenotype [31] . Similarly to the Nox3 mutant het mice, the formation and crystallization of otoconia in the hslt mice were also severely disturbed, while other morphological structures of the inner ear seemed to be normal [31] . In agreement with these results, another indispensable component of the functioning Nox3 complex, p22 phox , was also shown to be necessary for otoconia formation [32] . The nmf333 mutant mouse strain carries missense mutation in the transmembrane region eliminating the expression of the p22 phox protein [32] . A special staining method (von Kossa)
showed the lack of calcium carbonate crystals in the utriculus just like in the case of the Nox3-deficient head tilt animals. Along with the balance defects, the nmf333 animals also have severe immunodeficiency due to the lack of phagocyte oxidase (Nox2) activity [32] .
Although Noxo1 and Noxa1 were shown to interact in the Nox1 complex of colon epithelial cells [11] , Noxa1 knockouts do not show balance defects, indicating that Noxa1 is not part of the inner ear NADPH oxidase complex [33] .
Nox4
Nox4 was first identified in kidney epithelial cells [34] (Figure 1 ), but in the past 10 years the enzyme has been identified in several different cell types, including endothelial cells, vascular smooth muscle, fibroblasts, cardiomyocytes, skeletal muscle, osteoclasts, adipocytes, neurons, and microglia [1] . Although Nox4 is currently the most extensively studied Nox isoform, surprisingly few knockout studies have been published on Nox4. Research on this Nox isoform has been hampered by the lack of specific antibodies that can detect endogenously expressed protein [35] . Accordingly, the intracellular localization of Nox4 is still unclear and the protein was described at several intracellular locations including the nucleus, endoplasmic reticulum, focal adhesions, plasma membrane, and mitochondria.
In the mouse kidney, Nox4 is mainly expressed in proximal tubules although its mRNA was also detected in other segments of the nephron, including glomeruli and medullary collecting ducts [34] . It is of note that Nox4-deficient animals show no gross abnormality in their kidneys [28, 36] . Babelova et al. studied the course of three different chronic kidney disease models in mice with global or inducible Nox4 deletion [37] . Models included diabetes-induced kidney injury, unilateral ureter ligation, and 5/6 nephrectomy, respectively. The absence of Nox4 was not protective in either of the models, and the course of fibrosis induced by unilateral ureter obstruction was even slightly more severe in Nox4-deficient animals [37] . An independent study, using the same model of kidney fibrosis in a different Nox4-deficient strain, yielded similar results -the absence of Nox4 was found to be associated with more severe interstitial fibrosis [38] . Further analysis of the Nox4-deficient kidney revealed that the absence of the enzyme increased the apoptotic rate of tubular cells and reduced vascularization [38] . The lower interstitial capillary density was probably a consequence of decreased HIF-1/ expression. Interestingly, in ApoE-deficient mice the absence of Nox4 offered protection against glomerular damage in diabetic nephropathy [39] .
Hopefully in the future, Nox4 knockouts will also assist to elucidate the physiological role of Nox4 in the kidney. The high expression level in proximal tubular cells along with the constitutive ROS-producing activity suggest a yet to be identified physiological function for the enzyme.
Nox4 is also present in the heart, where its precise expression pattern remains to be determined. Zhang et al. studied the role of Nox4 in cardiac adaptation to pressure overload using Nox4 knockouts and transgenic animals that overexpressed Nox4 in a cardiac-specific manner [36] . Their results suggest that Nox4 has a protective role in chronic load-induced stress [36] . The signaling pathways behind the protective effect of Nox4 include higher induction of HIF-1/ resulting in elevated vascular endothelial growth factor (VEGF) levels and enhanced angiogenesis [36] . This study was the first to demonstrate that the absence of Nox4 might have deleterious consequences. Interestingly, in mice where Nox4 was deleted in a cardiomyocyte-specific manner, pressure overload evoked less severe pathological changes in Nox4 knockouts, suggesting a pathogenic role for Nox4 [40] . Further studies should clarify the reason for these conflicting findings; however, it should be mentioned that a more severe pressure overload was induced in the latter study. It is also important to note that results obtained with cell-specific knockouts could be misleading when the function of an organ is analyzed as a whole. As for the heart, three different cell types in the heart (cardiomyocytes, endothelial cells, fibroblasts) were described to express Nox4 [41] . Consequently, deletion of Nox4 activity in a cardiomyocytespecific manner does not ensure a complete loss of Nox4 activity in the organ.
Endothelial cells are a particularly rich source of Nox4 and the enzyme seems to have a protective role in blood vessels [42] . In response to ischemia, the formation of new blood vessels was found to be lowered in Nox4-deficient animals and angiotensin II-induced vascular dysfunction was also more severe in Nox4 knockouts. Loss of Nox4 activity was accompanied by reduced expression of endothelial nitric oxide synthase (eNOS) and heme oxygenase leading to decreased formation of protective endothelial mediators [42] . In a recent study, accelerated atherosclerosis was found in Nox4 knockout animals [43] that might be explained by reduced leukocyte adhesion to Nox4-deficient endothelial cells. Overexpression of Nox4 in an endothelium-specific manner reduces atherosclerosis in ApoE -/-mice, an observation that also points to an anti-atherosclerotic effect of Nox4-derived ROS [44] .
Nox4 is also expressed in the lung, where type II epithelial cells and endothelial cells contain the enzyme. In a bleomycin-induced fibrosis model, the lungs of Nox4 knockout mice showed less severe pathological changes than that of wild-type animals [45] . The protective effect of Nox4 deficiency was probably due to the reduced apoptotic rate of type II epithelial cells. A previous study, using RNA interference, already suggested that Nox4 might be important in the development of lung fibrosis. That study, however, implicated reduced formation of myofibroblasts as an explanation for the protective effect of Nox4 deficiency [46] .
The possible role of ROS in the pathogenesis of neurodegenerative diseases is currently a subject of intense research, and thus elucidating the function of Nox4 in the central nervous system (CNS) is also of great interest. In an ischemic stroke model induced by transient MCAO, Nox4-deficient mice developed less oxidative stress and were protected from brain damage [28] . In immunostaining experiments, the authors detected an induction of Nox4 in neurons, although Nox4 knockouts were not included as negative controls [28] . VAS2870, a non-specific inhibitor of Nox enzymes mimicked the effect of genetic Nox4 deletion, raising hopes for the development of an anti-stroke therapeutic strategy using Nox inhibitors. Experiments on Nox4 knockout animals revealed that the enzyme is also present in a subset of DRG neurons, where it has a role in nociceptive processing [47] . Although Nox4 was identified in nonmyelinated neurons, Nox4-mediated ROS production induced dysmyelination of a different fiber population in a mouse model of peripheral nerve injury.
Osteoclasts are among the cell types where Nox4 was first described [48] . Nox4 knockout animals have higher bone density, a phenotype that is likely caused by impaired formation and activation of osteoclasts [49] . In a murine model of postmenopausal osteoporosis, pharmacological or genetic inhibition of Nox4 reduced the loss of trabecular bone [49] .
Duox1 and Duox2
Duox1 and Duox2 were first cloned from porcine and human thyroid gland ( Figure 1 ) [50, 51] . For proper targeting and function, Duox enzymes must interact with Duox activator proteins DuoxA1 and DuoxA2 [52] . Homozygous nonsense mutation in Duox2 causing congenital hypothyroidism demonstrated its obligate function in thyroid hormone biosynthesis [6, 53] . Mice with a spontaneously developed missense Duox2 mutation develop the phenotype characteristic for congenital hypothyroidism [54] due to the loss of Duox2-mediated ROS production [55] . Simultaneous knockout of the two genes encoding DuoxA1 and DuoxA2 led to the development of the same phenotype [56] .
Duox expression is not confined to the thyroid gland; the enzyme is present on mucosal surfaces of the respiratory and gastrointestinal tract, where a host defense function was suggested [57] . According to the model introduced by Geiszt et al., Duox-produced H 2 O 2 supports lactoperoxidase to generate hypothiocyanite, which is an effective antimicrobial compound against a broad range of bacteria [58] [59] [60] . In non-vertebrates, such as Drosophila, zebrafish, and Caenorhabditis elegans, a growing cluster of data supports the indispensable role of Duox in gastrointestinal control of commensal, foodborne, or pathogenic microorganisms [61] [62] [63] . Recently, an interesting study on DuoxA double knockout mice confirmed the protective role of Duox2-derived H 2 O 2 , as it prevented the gastric colonization by Helicobacter felis and attendant inflammatory responses [64] . This study was the first in vivo genetic demonstration in a mammalian organism of how Duox can control the colonization of a noninvasive pathogen of the mucus layer. The innate immune modulatory effect of Duox-derived H 2 O 2 was further confirmed by a recent study in an ovalbumininduced allergic asthma model using the Duox1-and Duox2-deficient DuoxA -/-double knockouts, where reduced mucus cell metaplasia, decreased airway resistance, and lower level of Th2 cytokine secretion was found in the DuoxA -/-mice [65] . In a separate study, flagellin-stimulated expression of inflammation and immune response-related genes was attenuated in the nasal mucosa of the Duox2-deficient mice compared with wild-type animals [66] . Importantly, in the latter study Duox2 knockout animals were not hormone-supplemented, thus the profound effect of thyroid hormone deficiency on gene expression should also be considered. Since precise restoration of physiological thyroid hormone levels is probably difficult to achieve, conditional knockouts lacking Duox2 in a tissue-specific manner will be instrumental in the assessment of Duox2 function in mucosal host defense. Another interesting question is whether the specific deletion of Duox2 in colon epithelial cells affects the expression and function of Nox1, which is also highly expressed in the colon. It is possible that the two enzymes have some overlapping functions, although the differences in their regulation may be a sign of distinct biological functions. Nevertheless, the presence of two different Nox/Duox isoforms in colon epithelial cells highlights the importance of regulated ROS production in the colon.
Duox1 is also expressed in the thyroid gland, although its function remains unknown. Functional redundancy in hormone synthesis is unlikely since Duox1 cannot substitute for the loss of Duox2, and Duox1 knockout mice are not hypothyroid [67] . We detected Duox1 expression in mouse urothelium and showed in in vivo cystometry experiments using knockout mice that Duox1-derived H 2 O 2 attenuates urinary bladder contractions [67] . We propose that mechanical stretch of the bladder urothelium triggers Duox1 activation, but further studies are needed to elucidate whether H 2 O 2 acts directly or in a paracrine manner, diffusing to neighboring cells and acting on smooth muscle or nerve cells.
Concluding Remarks
There are several approaches to study the function of a particular gene. Although the use of pharmacological inhibitors, and more recently RNA interference, offer a quick way to assess gene function in cell culture or in vivo, it is important to keep in mind that specificity of these approaches is often insufficient. The creation of inheritable mutation in mice offers a more specific way to study gene function. Although the generation of knockout mouse models was generally time-consuming, recently discovered gene-modifying techniques have dramatically reduced the time needed for gene targeting [68] . Knockout mice models are now available for all mammalian Noxs and their regulators, except for Nox5, which is not expressed in mice. Experiments on gene-deficient animals have helped to understand the physiological function of Nox3 and confirmed the essential role of Duox2 in thyroid hormone synthesis. In the case of
Outstanding Questions
In sharp contrast to the pathology of Nox3 and Duox2 deficiencies, the absence of Nox1, Nox4, or Duox1 does not result in an obvious phenotype and knockout models for these genes did not help uncover their roles in organs where they were originally discovered. Thus, we still do not know:
What is the physiological function of Nox1 in the colon?
What is the role of Nox4 in kidney epithelial cells?
What is the function of epithelialexpressed Duox1 in different organs, including the thyroid?
What is the physiological role of Duox2 outside of the thyroid?
What is the function of Nox5? The absence of Nox5 in mice and rats calls for developing animal models of other species.
Nox1, Nox4, and Duox1, the hunt is still on for their main functions in organs where they are expressed at their highest levels (see Outstanding Questions). This is a major concern when considering the pharmacological targeting of these isoforms, because unexpected side effects may result from the inhibition. Several studies have documented the disease-modifying phenotypes of Nox1 and Nox4 knockouts, and in some cases the results suggest that pharmacological inhibition of their activity might have therapeutic value. However, several observations that document the deleterious effects of Nox gene deletion on disease progression offer the provocative conclusion that devising pharmacological tools to stimulate their activity would sometimes be more desirable.
The discovery of the Nox/Duox family of NADPH oxidases has dramatically transformed our view of ROS and oxidative stress. The fact that diverse cells and tissues express Nox/Duox enzymes proves that regulated production of ROS is an integral part of maintaining homeostasis. Thus, the traditional dogma that considered ROS as exclusively harmful substances is no longer acceptable and is gradually replaced by a more differentiated view on their role in physiology and pathophysiology. Hopefully, future experiments using Nox/Duox-deficient knockouts will help us to better comprehend their physiological functions and clarify the therapeutic potential of Nox/Duox inhibition.
